黄山胶囊收盘上涨1.40%，滚动市盈率41.15倍，总市值21.71亿元

Core Viewpoint - Huangshan Capsule's stock closed at 7.26 yuan, up 1.40%, with a rolling PE ratio of 41.15, marking a new low in 321 days, and a total market value of 2.171 billion yuan [1] Company Overview - Anhui Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules, being one of the earliest manufacturers in China with over 30 years of high-quality production history [1] - The company's main products include gelatin hollow capsules, enteric-coated gelatin hollow capsules, hydroxypropyl methylcellulose hollow capsules, and pullulan hollow capsules [1] - Huangshan Capsule is recognized for its contributions in the pharmaceutical packaging sector, holding notable awards and memberships, including being a member of the China Pharmaceutical Packaging Association and a vice-chair unit of the Pharmaceutical Hollow Capsule Committee [1] Financial Performance - For Q1 2025, the company reported operating revenue of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, reflecting a year-on-year growth of 22.90% with a sales gross margin of 29.26% [2] - The company's PE ratio (TTM) stands at 41.15, while the industry average is 50.80, and the industry median is 36.71 [2] Market Position - Huangshan Capsule ranks 84th in terms of PE ratio within the medical device industry, which has an average PE of 50.80 and a median of 36.71 [2] - The company has a total market value of 2.171 billion yuan, compared to the industry average market value of 10.836 billion yuan [2]